Back

The benefits of adding a defibrillator to cardiac resynchronization therapy - systematic review and meta-analysis

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Unraveling epidemiology in heart failure Cardiac Resynchronisation Therapy (CRT) HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Boglarka Veres

Semmelweis University, Budapest (Hungary)

5 More presentations in this session

Presentation thumbnail
Established and novel adiposity measures and their association with incident atrial fibrillation, heart failure and ischaemic heart disease in the general population
Mr V. Zwartkruis (Groningen, NL)
Abstract Slides
Presentation thumbnail
Socioeconomic factors determine maternal and fetal outcomes in women with peripartum cardiomyopathy: an ESC EORP registry study
Doctor C. Viljoen (Rondebosch, ZA)
Abstract Slides
Presentation thumbnail
Catheter ablation for atrial fibrillation in heart failure: a systematic review and meta-analysis
Doctor M. Maccallini (Milan, IT)
Abstract Slides
Presentation thumbnail
Cardiac resynchronization therapy practice who gets it and why? A comparison between ESC HF registry, CRT Survey II and SwedeHF.
Doctor P. Gatti (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Global prevalence of in-hospital complications, mortality and LV recovery in women with PPCM - a systematic review and meta-analysis.
Doctor J. Hoevelmann (Homburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Unraveling epidemiology in heart failure

The Event

Event poster

Heart Failure 2022

21 May - 24 May 2022
You may be interested in
thumbnail
Congress Presentation
Conduction system pacing in the current treatment of HFrEF patients
thumbnail
Congress Presentation
Device therapy: how to identify responders?
thumbnail
Congress Presentation
Cardiac resynchronisation therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources